Yaskawa Electric and Softbank plan to enable human-robot collaboration and more tasks by integrating AI and communications.

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Good day, and welcome to the IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025. The next presenting company is Flux Power Holdings Inc. [Operator Instructions] I'd now like to turn ...

Still, riders worry adding new stations will strain a system they see as already struggling. More Money for Harrell's ...

Disulfiram is a drug commonly used to treat alcohol use disorder. It works by deterring people from consuming booze. Also known as the brand name Antabuse, disulfiram blocks an enzyme in the liver ...

It’s happening now the thing we’ve waited for, a game-changer that hits like the last piece snapping into place across the EV ...

When people talk about broaching in general, oftentimes they’re referring to pull-style broaching, where you have a 3'-long ...

With FDA approval to treat marginal zone lymphoma (MZL), Bristol Myers Squibb’s Breyanzi has become the first CAR-T therapy ...

It’s not the first time OPM has attempted to merge disparate HR IT systems across government, but the agency said the current ...

The U.S. Food and Drug Administration (FDA) has approved Breyanzi (lisocabtagene maraleucel) for the treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least ...

CEO Will Bruey says people often get Varda wrong. The company isn't "in the space industry; we're in-space industry," he said ...

ORLANDO, Fla. — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in ...